文献速递物质与行为成瘾会诊联络精神医学

DSM-5槟榔使用障碍与口腔潜在恶性疾患的关联:6个槟榔流行亚洲人群研究

Association of DSM-5 Betel-Quid Use Disorder With Oral Potentially Malignant Disorder in 6 Betel-Quid Endemic Asian Populations.
PubMed 文献 · JAMA Psychiatry · 2018-01-01

该研究在6个槟榔流行的亚洲人群中对8922名成年人进行面对面访谈,使用DSM-5物质使用障碍标准评估槟榔使用障碍(BUD),并通过临床口腔检查评估口腔潜在恶性疾患(OPMD)。结果显示DSM-5症状可作为BUD的有效测量,当前槟榔使用者中BUD的12个月比例为86.0%,且BUD与OPMD风险显著相关。

要点

  • 当前槟榔使用者中DSM-5定义BUD的12个月比例高达86.0%。
  • 使用槟榔且无BUD者OPMD风险为不使用者的22.0倍(95%CI 4.3-112.4)。
  • 中重度BUD伴耐受症状者OPMD风险为不使用者的153.4倍(95%CI 33.4-703.6)。

核心结论

  • DSM-5症状可构成有效的槟榔使用障碍(BUD)结构,且BUD与口腔潜在恶性疾患(OPMD)风险相关。
  • 大多数当前亚洲槟榔使用者已患有BUD,中重度BUD者的耐受及更大用量或更长使用史与OPMD风险增强相关。

研究设计与样本

  • 研究采用面对面访谈,于2009年1月1日至2010年2月28日对来自亚洲槟榔联盟研究的8922名非机构化成年人随机样本进行调查,覆盖6个槟榔流行人群。
  • 统计分析于2015年1月1日至2016年12月31日进行。

主要发现

  • 8922名参与者中女性4564名、男性4358名,平均(SD)年龄44.2(0.2)岁。
  • 6个研究人群中DSM-5定义BUD的12个月患病率为18.0%(轻度3.2%、中度4.3%、重度10.5%)。
  • 当前槟榔使用者中DSM-5定义BUD的12个月比例为86.0%(轻度15.5%、中度20.6%、重度50.0%)。
  • 与不使用槟榔者相比,使用槟榔且无BUD者OPMD风险为22.0倍(95%CI 4.3-112.4,P<.001),轻度BUD者为9.6倍(95%CI 1.8-56.8,P=.01),中度BUD者为35.5倍(95%CI 4.3-292.3,P=.001),重度BUD者为27.5倍(95%CI 1.6-461.4,P=.02)。
  • 中重度BUD且使用槟榔并有耐受症状者OPMD风险为不使用者的153.4倍(95%CI 33.4-703.6),中重度BUD且使用槟榔并有更大用量或更长使用史者OPMD风险为不使用者的88.9倍(95%CI 16.6-476.5)。

关键数值与推荐

  • 当前槟榔使用者0-1个症状定义为无BUD,2-3个症状为轻度BUD,4-5个症状为中度BUD,6个及以上症状为重度BUD。
  • 性别、年龄、低教育水平、吸烟和饮酒与BUD显著相关;在槟榔使用者中,家庭使用、高使用频率和使用量与中重度BUD显著相关。

临床怎么用

  • 对槟榔使用者应使用DSM-5标准评估BUD,尤其关注耐受、使用量和使用史以识别OPMD高风险者。
  • BUD可作为精神科管理的新指征,需将槟榔使用障碍纳入临床评估与干预计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Betel-quid (BQ) is the fourth most popular psychoactive agent worldwide. An emerging trend across Asia is the addictive consumption of BQ, which is associated with oral cancer and other health consequences. OBJECTIVE: To investigate the validity and pattern of DSM-5-defined BQ use disorder (BUD) and its association with oral potentially malignant disorder (OPMD) among Asian populations. DESIGN, SETTING, AND PARTICIPANTS: In-person interviews were conducted from January 1, 2009, to February 28, 2010, among a random sample of 8922 noninstitutionalized adults from the Asian Betel-quid Consortium study, an Asian representative survey of 6 BQ-endemic populations. Statistical analysis was performed from January 1, 2015, to December 31, 2016. MAIN OUTCOMES AND MEASURES: Participants were evaluated for BUD using DSM-5 criteria for substance use disorder and for OPMD using a clinical oral examination. Current users of BQ with 0 to 1 symptoms were classified as having no BUD, those with 2 to 3 symptoms as having mild BUD, those with 4 to 5 symptoms as having moderate BUD, and those with 6 or more symptoms as having severe BUD. RESULTS: Among the 8922 participants (4564 women and 4358 men; mean [SD] age, 44.2 [0.2] years), DSM-5 symptoms showed sufficient unidimensionality to act as a valid measure for BUD. The 12-month prevalence of DSM-5-defined BUD in the 6 study populations was 18.0% (mild BUD, 3.2%; moderate BUD, 4.3%; and severe BUD, 10.5%). The 12-month proportion of DSM-5-defined BUD among current users of BQ was 86.0% (mild BUD, 15.5%; moderate BUD, 20.6%; and severe BUD, 50.0%). Sex, age, low educational level, smoking, and drinking were significantly associated with BUD. Among individuals who used BQ, family use, high frequency of use, and amount of BQ used were significantly linked to moderate to severe BUD. Compared with individuals who did not use BQ, those who used BQ and had no BUD showed a 22.0-fold (95% CI, 4.3-112.4) risk of OPMD (P < .001), whereas those with mild BUD showed a 9.6-fold (95% CI, 1.8-56.8) risk (P = .01), those with moderate BUD showed a 35.5-fold (95% CI, 4.3-292.3) risk (P = .001), and those with severe BUD showed a 27.5-fold (95% CI, 1.6-461.4) risk of OPMD (P = .02). Individuals with moderate to severe BUD who used BQ and had the symptom of tolerance had a 153.4-fold (95% CI, 33.4-703.6) higher risk of OPMD than those who did not use BQ, and those with moderate to severe BUD who used BQ and had a larger amount or longer history of BQ use had an 88.9-fold (95% CI, 16.6-476.5) higher risk of OPMD than those who did not use BQ. CONCLUSIONS AND RELEVANCE: This international study gathered data about BQ users across 6 Asian populations, and it demonstrates that DSM-5 symptoms could fulfill a BUD construct. Most current Asian users of BQ already have BUD, which is correlated with risk of OPMD. Among individuals with moderate to severe BUD who used BQ, tolerance and a larger amount or longer history of BQ use are the key symptoms that correlated with enhanced risk of OPMD. These findings play an important role in providing a new indication of an additional psychiatric management plan for users of BQ who have BUD.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lee CH, Ko AM, Yang FM, et al. Association of DSM-5 Betel-Quid Use Disorder With Oral Potentially Malignant Disorder in 6 Betel-Quid Endemic Asian Populations. JAMA Psychiatry. 2018. PMID: 29417149. doi:10.1001/jamapsychiatry.2017.4307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。